Global Tumor Excision Device Market Research Report 2026

Tumor Excision Device Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Tumor Excision Device competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

A Tumor Excision Device refers to a class of surgical instruments and energy-based platforms used to precisely cut, dissect, separate, achieve hemostasis, and retrieve specimens when removing tumors or suspicious lesions. It supports multiple approaches including open surgery, laparoscopy/thoracoscopy, endoscopy, and robot-assisted procedures. Device forms may include electrosurgical cutting and vessel-sealing instruments, ultrasonic cutting systems, RF/microwave resection–ablation hybrids, endoscopic mucosal/submucosal resection tools (EMR/ESD), and tissue morcellation and retrieval systems, often integrated with smoke evacuation, irrigation–suction, visualization, and navigation workflows. Its core value is enabling efficient and reproducible excision under oncologic margin principles, reducing bleeding and thermal injury risk, and delivering high-quality specimens for pathology and staging. In 2025, global Tumor Excision Device production reached approximately 2.71 million Units and price is about 2000 USD/Unit.The average gross profit margin of this product is 55%.

Cancer care is accelerating toward early detection and minimally invasive intervention, increasing the share of resectable cases and the penetration of advanced excision devices as high-frequency OR essentials. Perioperative refinement and ERAS-driven efficiency targets promote adoption of integrated cut-and-seal energy devices that reduce instrument exchanges and operative time. Meanwhile, expansion of hybrid ORs and robotic platforms strengthens demand for interface standardization, procedure-based toolchain standardization, and platform-driven recurring consumable models.Safety margins and clinical evidence requirements are stringent. Thermal spread and smoke management, reliable handling of fragile vessels and high-bleeding tissues, and anatomical variability across specialties require consistent energy output, temperature control, and mechanical reliability. Under tendering and cost-containment pressures, commoditized products face pricing compression and higher access thresholds, forcing suppliers to defend value through real-world complication control, shorter learning curves, and workflow support. Supply stability and inadequate training/service capability can also directly undermine sustained hospital adoption.Demand is shifting from single-device performance to procedure-level solutions, prioritizing compatibility with laparoscopic/endoscopic/robotic platforms, excision and hemostasis efficiency, low thermal damage, and specimen integrity with traceable retrieval. Growth of endoscopic local resection for early tumors is driving upgrades in precision knives, traction/exposure tools, and retrieval systems, while complex solid-tumor surgery increasingly values multi-energy synergy, intraoperative visualization/navigation, and smoke control. Traceable single-use consumables, surgical data capture, and digital linkage to perioperative management are emerging as new differentiation vectors.Upstream inputs include medical metals and polymers, energy/control components, and sterile packaging. Blades and jaws commonly use stainless steel, titanium alloys, and wear-resistant coating systems; insulation and handles rely on high-performance polymers and composites. Energy platforms require generator modules, cables, sensors, and control chips, and many disposables depend on precision molding and microfabrication. For electrosurgical/ultrasonic/RF/microwave devices, heat resistance, electrical insulation, sealing integrity, sterilization compatibility, and lot consistency are baseline requirements. Supply-chain advantage hinges on precision manufacturing yield, stable sourcing of key electronics and advanced materials, and robust quality systems with cost-efficient scale delivery.

This report delivers a comprehensive overview of the global Tumor Excision Device market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Tumor Excision Device. The Tumor Excision Device market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Tumor Excision Device market comprehensively. Regional market sizes by Type, by Application, by Surgical Approach, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Tumor Excision Device manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Tumor Excision Device Market Report

Chapter Outline

1.1 Product Definition

1.2 Tumor Excision Device by Type

1.2.1 Global Tumor Excision Device Market Value by Type: 2025 vs 2032

1.2.2 Electrosurgical Devices

1.2.3 Ultrasonic Devices

1.2.4 Laser Resection

1.3 Tumor Excision Device by Surgical Approach

1.3.1 Global Tumor Excision Device Market Value by Surgical Approach: 2025 vs 2032

1.3.2 Open Surgery

1.3.3 Laparoscopic/Thoracoscopic

1.3.4 Endoscopic

1.4 Tumor Excision Device by Cnacer Type

1.4.1 Global Tumor Excision Device Market Value by Cnacer Type: 2025 vs 2032

1.4.2 Solid Tumors

1.4.3 Hematologic

1.5 Tumor Excision Device by Application

1.5.1 Global Tumor Excision Device Market Value by Application: 2025 vs 2032

1.5.2 Hospitals

1.5.3 Cancer Centers

1.5.4 Other

1.6 Global Tumor Excision Device Market Size Estimates and Forecasts

1.6.1 Global Tumor Excision Device Revenue 2021–2032

1.6.2 Global Tumor Excision Device Sales 2021–2032

1.6.3 Global Tumor Excision Device Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2.1 Global Tumor Excision Device Sales Market Share by Manufacturers (2021–2026)

2.2 Global Tumor Excision Device Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Tumor Excision Device Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Tumor Excision Device, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Tumor Excision Device, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Tumor Excision Device, Product Types and Applications

2.7 Global Key Manufacturers of Tumor Excision Device, Date of Entry into the Industry

2.8 Global Tumor Excision Device Market Competitive Situation and Trends

2.8.1 Global Tumor Excision Device Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Tumor Excision Device Players Market Share by Revenue

2.8.3 Global Tumor Excision Device Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Tumor Excision Device Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Tumor Excision Device Sales by Region: 2021–2032

3.2.1 Global Tumor Excision Device Sales by Region: 2021–2026

3.2.2 Global Tumor Excision Device Sales by Region: 2027–2032

3.3 Global Tumor Excision Device Revenue by Region: 2021–2032

3.3.1 Global Tumor Excision Device Revenue by Region: 2021–2026

3.3.2 Global Tumor Excision Device Revenue by Region: 2027–2032

3.4 North America Tumor Excision Device Market Facts & Figures by Country

3.4.1 North America Tumor Excision Device Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Tumor Excision Device Sales by Country (2021–2032)

3.4.3 North America Tumor Excision Device Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Tumor Excision Device Market Facts & Figures by Country

3.5.1 Europe Tumor Excision Device Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Tumor Excision Device Sales by Country (2021–2032)

3.5.3 Europe Tumor Excision Device Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Tumor Excision Device Market Facts & Figures by Region

3.6.1 Asia Pacific Tumor Excision Device Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Tumor Excision Device Sales by Region (2021–2032)

3.6.3 Asia Pacific Tumor Excision Device Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Tumor Excision Device Market Facts & Figures by Country

3.7.1 Latin America Tumor Excision Device Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Tumor Excision Device Sales by Country (2021–2032)

3.7.3 Latin America Tumor Excision Device Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Tumor Excision Device Market Facts & Figures by Country

3.8.1 Middle East and Africa Tumor Excision Device Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Tumor Excision Device Sales by Country (2021–2032)

3.8.3 Middle East and Africa Tumor Excision Device Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Tumor Excision Device Sales by Type (2021–2032)

4.1.1 Global Tumor Excision Device Sales by Type (2021–2026)

4.1.2 Global Tumor Excision Device Sales by Type (2027–2032)

4.1.3 Global Tumor Excision Device Sales Market Share by Type (2021–2032)

4.2 Global Tumor Excision Device Revenue by Type (2021–2032)

4.2.1 Global Tumor Excision Device Revenue by Type (2021–2026)

4.2.2 Global Tumor Excision Device Revenue by Type (2027–2032)

4.2.3 Global Tumor Excision Device Revenue Market Share by Type (2021–2032)

4.3 Global Tumor Excision Device Price by Type (2021–2032)

5.1 Global Tumor Excision Device Sales by Application (2021–2032)

5.1.1 Global Tumor Excision Device Sales by Application (2021–2026)

5.1.2 Global Tumor Excision Device Sales by Application (2027–2032)

5.1.3 Global Tumor Excision Device Sales Market Share by Application (2021–2032)

5.2 Global Tumor Excision Device Revenue by Application (2021–2032)

5.2.1 Global Tumor Excision Device Revenue by Application (2021–2026)

5.2.2 Global Tumor Excision Device Revenue by Application (2027–2032)

5.2.3 Global Tumor Excision Device Revenue Market Share by Application (2021–2032)

5.3 Global Tumor Excision Device Price by Application (2021–2032)

6.1 Medtronic

6.1.1 Medtronic Company Information

6.1.2 Medtronic Description and Business Overview

6.1.3 Medtronic Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Medtronic Tumor Excision Device Product Portfolio

6.1.5 Medtronic Recent Developments/Updates

6.2 J &J

6.2.1 J &J Company Information

6.2.2 J &J Description and Business Overview

6.2.3 J &J Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 J &J Tumor Excision Device Product Portfolio

6.2.5 J &J Recent Developments/Updates

6.3 B. Braun (Aesculap)

6.3.1 B. Braun (Aesculap) Company Information

6.3.2 B. Braun (Aesculap) Description and Business Overview

6.3.3 B. Braun (Aesculap) Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 B. Braun (Aesculap) Tumor Excision Device Product Portfolio

6.3.5 B. Braun (Aesculap) Recent Developments/Updates

6.4 ConMed

6.4.1 ConMed Company Information

6.4.2 ConMed Description and Business Overview

6.4.3 ConMed Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 ConMed Tumor Excision Device Product Portfolio

6.4.5 ConMed Recent Developments/Updates

6.5 Olympus

6.5.1 Olympus Company Information

6.5.2 Olympus Description and Business Overview

6.5.3 Olympus Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Olympus Tumor Excision Device Product Portfolio

6.5.5 Olympus Recent Developments/Updates

6.6 ERBE

6.6.1 ERBE Company Information

6.6.2 ERBE Description and Business Overview

6.6.3 ERBE Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 ERBE Tumor Excision Device Product Portfolio

6.6.5 ERBE Recent Developments/Updates

6.7 LED SPA

6.7.1 LED SPA Company Information

6.7.2 LED SPA Description and Business Overview

6.7.3 LED SPA Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 LED SPA Tumor Excision Device Product Portfolio

6.7.5 LED SPA Recent Developments/Updates

6.8 Cooper Surgical

6.8.1 Cooper Surgical Company Information

6.8.2 Cooper Surgical Description and Business Overview

6.8.3 Cooper Surgical Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Cooper Surgical Tumor Excision Device Product Portfolio

6.8.5 Cooper Surgical Recent Developments/Updates

6.9 Karl Storz

6.9.1 Karl Storz Company Information

6.9.2 Karl Storz Description and Business Overview

6.9.3 Karl Storz Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Karl Storz Tumor Excision Device Product Portfolio

6.9.5 Karl Storz Recent Developments/Updates

6.10 KLS Martin

6.10.1 KLS Martin Company Information

6.10.2 KLS Martin Description and Business Overview

6.10.3 KLS Martin Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 KLS Martin Tumor Excision Device Product Portfolio

6.10.5 KLS Martin Recent Developments/Updates

6.11 Soering

6.11.1 Soering Company Information

6.11.2 Soering Description and Business Overview

6.11.3 Soering Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Soering Tumor Excision Device Product Portfolio

6.11.5 Soering Recent Developments/Updates

6.12 Utah Medical

6.12.1 Utah Medical Company Information

6.12.2 Utah Medical Description and Business Overview

6.12.3 Utah Medical Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)

6.12.4 Utah Medical Tumor Excision Device Product Portfolio

6.12.5 Utah Medical Recent Developments/Updates

6.13 Symmetry Surgical (Bovie)

6.13.1 Symmetry Surgical (Bovie) Company Information

6.13.2 Symmetry Surgical (Bovie) Description and Business Overview

6.13.3 Symmetry Surgical (Bovie) Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)

6.13.4 Symmetry Surgical (Bovie) Tumor Excision Device Product Portfolio

6.13.5 Symmetry Surgical (Bovie) Recent Developments/Updates

6.14 Eschmann

6.14.1 Eschmann Company Information

6.14.2 Eschmann Description and Business Overview

6.14.3 Eschmann Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)

6.14.4 Eschmann Tumor Excision Device Product Portfolio

6.14.5 Eschmann Recent Developments/Updates

6.15 Meyer-Haake

6.15.1 Meyer-Haake Company Information

6.15.2 Meyer-Haake Description and Business Overview

6.15.3 Meyer-Haake Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)

6.15.4 Meyer-Haake Tumor Excision Device Product Portfolio

6.15.5 Meyer-Haake Recent Developments/Updates

6.16 Ellman

6.16.1 Ellman Company Information

6.16.2 Ellman Description and Business Overview

6.16.3 Ellman Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)

6.16.4 Ellman Tumor Excision Device Product Portfolio

6.16.5 Ellman Recent Developments/Updates

6.17 IBBAB

6.17.1 IBBAB Company Information

6.17.2 IBBAB Description and Business Overview

6.17.3 IBBAB Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)

6.17.4 IBBAB Tumor Excision Device Product Portfolio

6.17.5 IBBAB Recent Developments/Updates

6.18 Lamidey

6.18.1 Lamidey Company Information

6.18.2 Lamidey Description and Business Overview

6.18.3 Lamidey Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)

6.18.4 Lamidey Tumor Excision Device Product Portfolio

6.18.5 Lamidey Recent Developments/Updates

6.19 Bowa

6.19.1 Bowa Company Information

6.19.2 Bowa Description and Business Overview

6.19.3 Bowa Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)

6.19.4 Bowa Tumor Excision Device Product Portfolio

6.19.5 Bowa Recent Developments/Updates

6.20 Union Medical

6.20.1 Union Medical Company Information

6.20.2 Union Medical Description and Business Overview

6.20.3 Union Medical Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)

6.20.4 Union Medical Tumor Excision Device Product Portfolio

6.20.5 Union Medical Recent Developments/Updates

6.21 Shanghai Hutong

6.21.1 Shanghai Hutong Company Information

6.21.2 Shanghai Hutong Description and Business Overview

6.21.3 Shanghai Hutong Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)

6.21.4 Shanghai Hutong Tumor Excision Device Product Portfolio

6.21.5 Shanghai Hutong Recent Developments/Updates

6.22 KINDY ELECTRONIC

6.22.1 KINDY ELECTRONIC Company Information

6.22.2 KINDY ELECTRONIC Description and Business Overview

6.22.3 KINDY ELECTRONIC Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)

6.22.4 KINDY ELECTRONIC Tumor Excision Device Product Portfolio

6.22.5 KINDY ELECTRONIC Recent Developments/Updates

6.23 Heal Force

6.23.1 Heal Force Company Information

6.23.2 Heal Force Description and Business Overview

6.23.3 Heal Force Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)

6.23.4 Heal Force Tumor Excision Device Product Portfolio

6.23.5 Heal Force Recent Developments/Updates

6.24 Changzhou Yanling

6.24.1 Changzhou Yanling Company Information

6.24.2 Changzhou Yanling Description and Business Overview

6.24.3 Changzhou Yanling Tumor Excision Device Sales, Revenue, and Gross Margin (2021–2026)

6.24.4 Changzhou Yanling Tumor Excision Device Product Portfolio

6.24.5 Changzhou Yanling Recent Developments/Updates

7.1 Tumor Excision Device Industry Chain Analysis

7.2 Tumor Excision Device Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Tumor Excision Device Production Mode & Process Analysis

7.4 Tumor Excision Device Sales and Marketing

7.4.1 Tumor Excision Device Sales Channels

7.4.2 Tumor Excision Device Distributors

7.5 Tumor Excision Device Customer Analysis

8.1 Tumor Excision Device Industry Trends

8.2 Tumor Excision Device Market Drivers

8.3 Tumor Excision Device Market Challenges

8.4 Tumor Excision Device Market Restraints

8.5 Impact of U.S. Tariffs

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

 Table 1. Global Tumor Excision Device Market Value by Type (US$ Million), 2025 vs 2032

 Table 2. Global Tumor Excision Device Market Value by Surgical Approach (US$ Million), 2025 vs 2032

 Table 3. Global Tumor Excision Device Market Value by Cnacer Type (US$ Million), 2025 vs 2032

 Table 4. Global Tumor Excision Device Market Value by Application (US$ Million), 2025 vs 2032

 Table 5. Global Tumor Excision Device Market Competitive Situation by Manufacturers in 2025

 Table 6. Global Tumor Excision Device Sales (Units) of Key Manufacturers (2021–2026)

 Table 7. Global Tumor Excision Device Sales Market Share by Manufacturers (2021–2026)

 Table 8. Global Tumor Excision Device Revenue (US$ Million) by Manufacturers (2021–2026)

 Table 9. Global Tumor Excision Device Revenue Share by Manufacturers (2021–2026)

 Table 10. Global Market Tumor Excision Device Average Price (US$/Unit) of Key Manufacturers (2021–2026)

 Table 11. Global Key Players of Tumor Excision Device, Industry Ranking, 2023 vs 2024 vs 2025

 Table 12. Global Key Manufacturers of Tumor Excision Device, Manufacturing Sites and Headquarters

 Table 13. Global Key Manufacturers of Tumor Excision Device, Product Types and Applications

 Table 14. Global Key Manufacturers of Tumor Excision Device, Date of Entry into the Industry

 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

 Table 16. Global Tumor Excision Device Companies by Tier (Tier 1, Tier 2, Tier 3), based on Tumor Excision Device Revenue, 2025

 Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

 Table 18. Global Tumor Excision Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

 Table 19. Global Tumor Excision Device Sales by Region (Units), 2021–2026

 Table 20. Global Tumor Excision Device Sales Market Share by Region (2021–2026)

 Table 21. Global Tumor Excision Device Sales by Region (Units), 2027–2032

 Table 22. Global Tumor Excision Device Sales Market Share by Region (2027–2032)

 Table 23. Global Tumor Excision Device Revenue by Region (US$ Million), 2021–2026

 Table 24. Global Tumor Excision Device Revenue Market Share by Region (2021–2026)

 Table 25. Global Tumor Excision Device Revenue by Region (US$ Million), 2027–2032

 Table 26. Global Tumor Excision Device Revenue Market Share by Region (2027–2032)

 Table 27. North America Tumor Excision Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 28. North America Tumor Excision Device Sales by Country (Units), 2021–2026

 Table 29. North America Tumor Excision Device Sales by Country (Units), 2027–2032

 Table 30. North America Tumor Excision Device Revenue by Country (US$ Million), 2021–2026

 Table 31. North America Tumor Excision Device Revenue by Country (US$ Million), 2027–2032

 Table 32. Europe Tumor Excision Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 33. Europe Tumor Excision Device Sales by Country (Units), 2021–2026

 Table 34. Europe Tumor Excision Device Sales by Country (Units), 2027–2032

 Table 35. Europe Tumor Excision Device Revenue by Country (US$ Million), 2021–2026

 Table 36. Europe Tumor Excision Device Revenue by Country (US$ Million), 2027–2032

 Table 37. Asia Pacific Tumor Excision Device Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

 Table 38. Asia Pacific Tumor Excision Device Sales by Region (Units), 2021–2026

 Table 39. Asia Pacific Tumor Excision Device Sales by Region (Units), 2027–2032

 Table 40. Asia Pacific Tumor Excision Device Revenue by Region (US$ Million), 2021–2026

 Table 41. Asia Pacific Tumor Excision Device Revenue by Region (US$ Million), 2027–2032

 Table 42. Latin America Tumor Excision Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 43. Latin America Tumor Excision Device Sales by Country (Units), 2021–2026

 Table 44. Latin America Tumor Excision Device Sales by Country (Units), 2027–2032

 Table 45. Latin America Tumor Excision Device Revenue by Country (US$ Million), 2021–2026

 Table 46. Latin America Tumor Excision Device Revenue by Country (US$ Million), 2027–2032

 Table 47. Middle East and Africa Tumor Excision Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 48. Middle East and Africa Tumor Excision Device Sales by Country (Units), 2021–2026

 Table 49. Middle East and Africa Tumor Excision Device Sales by Country (Units), 2027–2032

 Table 50. Middle East and Africa Tumor Excision Device Revenue by Country (US$ Million), 2021–2026

 Table 51. Middle East and Africa Tumor Excision Device Revenue by Country (US$ Million), 2027–2032

 Table 52. Global Tumor Excision Device Sales (Units) by Type (2021–2026)

 Table 53. Global Tumor Excision Device Sales (Units) by Type (2027–2032)

 Table 54. Global Tumor Excision Device Sales Market Share by Type (2021–2026)

 Table 55. Global Tumor Excision Device Sales Market Share by Type (2027–2032)

 Table 56. Global Tumor Excision Device Revenue (US$ Million) by Type (2021–2026)

 Table 57. Global Tumor Excision Device Revenue (US$ Million) by Type (2027–2032)

 Table 58. Global Tumor Excision Device Revenue Market Share by Type (2021–2026)

 Table 59. Global Tumor Excision Device Revenue Market Share by Type (2027–2032)

 Table 60. Global Tumor Excision Device Price (US$/Unit) by Type (2021–2026)

 Table 61. Global Tumor Excision Device Price (US$/Unit) by Type (2027–2032)

 Table 62. Global Tumor Excision Device Sales (Units) by Application (2021–2026)

 Table 63. Global Tumor Excision Device Sales (Units) by Application (2027–2032)

 Table 64. Global Tumor Excision Device Sales Market Share by Application (2021–2026)

 Table 65. Global Tumor Excision Device Sales Market Share by Application (2027–2032)

 Table 66. Global Tumor Excision Device Revenue (US$ Million) by Application (2021–2026)

 Table 67. Global Tumor Excision Device Revenue (US$ Million) by Application (2027–2032)

 Table 68. Global Tumor Excision Device Revenue Market Share by Application (2021–2026)

 Table 69. Global Tumor Excision Device Revenue Market Share by Application (2027–2032)

 Table 70. Global Tumor Excision Device Price (US$/Unit) by Application (2021–2026)

 Table 71. Global Tumor Excision Device Price (US$/Unit) by Application (2027–2032)

 Table 72. Medtronic Company Information

 Table 73. Medtronic Description and Business Overview

 Table 74. Medtronic Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 75. Medtronic Tumor Excision Device Product

 Table 76. Medtronic Recent Developments/Updates

 Table 77. J &J Company Information

 Table 78. J &J Description and Business Overview

 Table 79. J &J Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 80. J &J Tumor Excision Device Product

 Table 81. J &J Recent Developments/Updates

 Table 82. B. Braun (Aesculap) Company Information

 Table 83. B. Braun (Aesculap) Description and Business Overview

 Table 84. B. Braun (Aesculap) Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 85. B. Braun (Aesculap) Tumor Excision Device Product

 Table 86. B. Braun (Aesculap) Recent Developments/Updates

 Table 87. ConMed Company Information

 Table 88. ConMed Description and Business Overview

 Table 89. ConMed Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 90. ConMed Tumor Excision Device Product

 Table 91. ConMed Recent Developments/Updates

 Table 92. Olympus Company Information

 Table 93. Olympus Description and Business Overview

 Table 94. Olympus Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 95. Olympus Tumor Excision Device Product

 Table 96. Olympus Recent Developments/Updates

 Table 97. ERBE Company Information

 Table 98. ERBE Description and Business Overview

 Table 99. ERBE Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 100. ERBE Tumor Excision Device Product

 Table 101. ERBE Recent Developments/Updates

 Table 102. LED SPA Company Information

 Table 103. LED SPA Description and Business Overview

 Table 104. LED SPA Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 105. LED SPA Tumor Excision Device Product

 Table 106. LED SPA Recent Developments/Updates

 Table 107. Cooper Surgical Company Information

 Table 108. Cooper Surgical Description and Business Overview

 Table 109. Cooper Surgical Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 110. Cooper Surgical Tumor Excision Device Product

 Table 111. Cooper Surgical Recent Developments/Updates

 Table 112. Karl Storz Company Information

 Table 113. Karl Storz Description and Business Overview

 Table 114. Karl Storz Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 115. Karl Storz Tumor Excision Device Product

 Table 116. Karl Storz Recent Developments/Updates

 Table 117. KLS Martin Company Information

 Table 118. KLS Martin Description and Business Overview

 Table 119. KLS Martin Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 120. KLS Martin Tumor Excision Device Product

 Table 121. KLS Martin Recent Developments/Updates

 Table 122. Soering Company Information

 Table 123. Soering Description and Business Overview

 Table 124. Soering Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 125. Soering Tumor Excision Device Product

 Table 126. Soering Recent Developments/Updates

 Table 127. Utah Medical Company Information

 Table 128. Utah Medical Description and Business Overview

 Table 129. Utah Medical Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 130. Utah Medical Tumor Excision Device Product

 Table 131. Utah Medical Recent Developments/Updates

 Table 132. Symmetry Surgical (Bovie) Company Information

 Table 133. Symmetry Surgical (Bovie) Description and Business Overview

 Table 134. Symmetry Surgical (Bovie) Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 135. Symmetry Surgical (Bovie) Tumor Excision Device Product

 Table 136. Symmetry Surgical (Bovie) Recent Developments/Updates

 Table 137. Eschmann Company Information

 Table 138. Eschmann Description and Business Overview

 Table 139. Eschmann Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 140. Eschmann Tumor Excision Device Product

 Table 141. Eschmann Recent Developments/Updates

 Table 142. Meyer-Haake Company Information

 Table 143. Meyer-Haake Description and Business Overview

 Table 144. Meyer-Haake Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 145. Meyer-Haake Tumor Excision Device Product

 Table 146. Meyer-Haake Recent Developments/Updates

 Table 147. Ellman Company Information

 Table 148. Ellman Description and Business Overview

 Table 149. Ellman Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 150. Ellman Tumor Excision Device Product

 Table 151. Ellman Recent Developments/Updates

 Table 152. IBBAB Company Information

 Table 153. IBBAB Description and Business Overview

 Table 154. IBBAB Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 155. IBBAB Tumor Excision Device Product

 Table 156. IBBAB Recent Developments/Updates

 Table 157. Lamidey Company Information

 Table 158. Lamidey Description and Business Overview

 Table 159. Lamidey Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 160. Lamidey Tumor Excision Device Product

 Table 161. Lamidey Recent Developments/Updates

 Table 162. Bowa Company Information

 Table 163. Bowa Description and Business Overview

 Table 164. Bowa Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 165. Bowa Tumor Excision Device Product

 Table 166. Bowa Recent Developments/Updates

 Table 167. Union Medical Company Information

 Table 168. Union Medical Description and Business Overview

 Table 169. Union Medical Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 170. Union Medical Tumor Excision Device Product

 Table 171. Union Medical Recent Developments/Updates

 Table 172. Shanghai Hutong Company Information

 Table 173. Shanghai Hutong Description and Business Overview

 Table 174. Shanghai Hutong Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 175. Shanghai Hutong Tumor Excision Device Product

 Table 176. Shanghai Hutong Recent Developments/Updates

 Table 177. KINDY ELECTRONIC Company Information

 Table 178. KINDY ELECTRONIC Description and Business Overview

 Table 179. KINDY ELECTRONIC Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 180. KINDY ELECTRONIC Tumor Excision Device Product

 Table 181. KINDY ELECTRONIC Recent Developments/Updates

 Table 182. Heal Force Company Information

 Table 183. Heal Force Description and Business Overview

 Table 184. Heal Force Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 185. Heal Force Tumor Excision Device Product

 Table 186. Heal Force Recent Developments/Updates

 Table 187. Changzhou Yanling Company Information

 Table 188. Changzhou Yanling Description and Business Overview

 Table 189. Changzhou Yanling Tumor Excision Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 190. Changzhou Yanling Tumor Excision Device Product

 Table 191. Changzhou Yanling Recent Developments/Updates

 Table 192. Key Raw Materials Lists

 Table 193. Raw Materials Key Suppliers Lists

 Table 194. Tumor Excision Device Distributors List

 Table 195. Tumor Excision Device Customers List

 Table 196. Tumor Excision Device Market Trends

 Table 197. Tumor Excision Device Market Drivers

 Table 198. Tumor Excision Device Market Challenges

 Table 199. Tumor Excision Device Market Restraints

 Table 200. Research Programs/Design for This Report

 Table 201. Key Data Information from Secondary Sources

 Table 202. Key Data Information from Primary Sources

 Table 203. Authors List of This Report

List of Figures

 Figure 1. Product Picture of Tumor Excision Device

 Figure 2. Global Tumor Excision Device Market Value by Type (US$ Million), 2021–2032

 Figure 3. Global Tumor Excision Device Market Share by Type: 2025 & 2032

 Figure 4. Electrosurgical Devices Product Picture

 Figure 5. Ultrasonic Devices Product Picture

 Figure 6. Laser Resection Product Picture

 Figure 7. Global Tumor Excision Device Market Value by Surgical Approach (US$ Million), 2021–2032

 Figure 8. Global Tumor Excision Device Market Share by Surgical Approach: 2025 vs 2032

 Figure 9. Open Surgery Product Picture

 Figure 10. Laparoscopic/Thoracoscopic Product Picture

 Figure 11. Endoscopic Product Picture

 Figure 12. Global Tumor Excision Device Market Value by Cnacer Type (US$ Million), 2021–2032

 Figure 13. Global Tumor Excision Device Market Share by Cnacer Type: 2025 vs 2032

 Figure 14. Solid Tumors Product Picture

 Figure 15. Hematologic Product Picture

 Figure 16. Global Tumor Excision Device Market Value by Application (US$ Million), 2021–2032

 Figure 17. Global Tumor Excision Device Market Share by Application: 2025 & 2032

 Figure 18. Hospitals

 Figure 19. Cancer Centers

 Figure 20. Other

 Figure 21. Global Tumor Excision Device Revenue, (US$ Million), 2021 vs 2025 vs 2032

 Figure 22. Global Tumor Excision Device Market Size (US$ Million), 2021–2032

 Figure 23. Global Tumor Excision Device Sales (Units), 2021–2032

 Figure 24. Global Tumor Excision Device Average Price (US$/Unit), 2021–2032

 Figure 25. Tumor Excision Device Report Years Considered

 Figure 26. Tumor Excision Device Sales Share by Manufacturers in 2025

 Figure 27. Global Tumor Excision Device Revenue Share by Manufacturers in 2025

 Figure 28. Top 5 and Top 10 Global Tumor Excision Device Players: Market Share by Revenue in Tumor Excision Device in 2025

 Figure 29. Tumor Excision Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

 Figure 30. Global Tumor Excision Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

 Figure 31. North America Tumor Excision Device Sales Market Share by Country (2021–2032)

 Figure 32. North America Tumor Excision Device Revenue Market Share by Country (2021–2032)

 Figure 33. United States Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 34. Canada Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 35. Europe Tumor Excision Device Sales Market Share by Country (2021–2032)

 Figure 36. Europe Tumor Excision Device Revenue Market Share by Country (2021–2032)

 Figure 37. Germany Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 38. France Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 39. U.K. Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 40. Italy Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 41. Russia Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 42. Asia Pacific Tumor Excision Device Sales Market Share by Region (2021–2032)

 Figure 43. Asia Pacific Tumor Excision Device Revenue Market Share by Region (2021–2032)

 Figure 44. China Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 45. Japan Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 46. South Korea Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 47. India Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 48. Australia Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 49. China Taiwan Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 50. Southeast Asia Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 51. Latin America Tumor Excision Device Sales Market Share by Country (2021–2032)

 Figure 52. Latin America Tumor Excision Device Revenue Market Share by Country (2021–2032)

 Figure 53. Mexico Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 54. Brazil Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 55. Argentina Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 56. Colombia Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 57. Middle East and Africa Tumor Excision Device Sales Market Share by Country (2021–2032)

 Figure 58. Middle East and Africa Tumor Excision Device Revenue Market Share by Country (2021–2032)

 Figure 59. Turkey Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 60. Saudi Arabia Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 61. UAE Tumor Excision Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 62. Global Sales Market Share of Tumor Excision Device by Type (2021–2032)

 Figure 63. Global Revenue Market Share of Tumor Excision Device by Type (2021–2032)

 Figure 64. Global Tumor Excision Device Price (US$/Unit) by Type (2021–2032)

 Figure 65. Global Sales Market Share of Tumor Excision Device by Application (2021–2032)

 Figure 66. Global Revenue Market Share of Tumor Excision Device by Application (2021–2032)

 Figure 67. Global Tumor Excision Device Price (US$/Unit) by Application (2021–2032)

 Figure 68. Tumor Excision Device Value Chain

 Figure 69. Channels of Distribution (Direct Vs Distribution)

 Figure 70. Bottom-up and Top-down Approaches for This Report

 Figure 71. Data Triangulation

 Figure 72. Key Executives Interviewed